Treatment and outcome of acquired haemophilia A with a standard conventional regimen in a cohort without associated conditions

Haemophilia

Volumn 12, Issue 4, 2006, Pages 423-428

  Ng, Heng Joo ^a   Tan, D C L ^a   Lee, L H ^a  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

Acquired factor VIII inhibitors; Bleeding; Immunosuppressants; Response; Toxicity

Indexed keywords

ALLOANTIBODY; BLOOD CLOTTING FACTOR 7A; BLOOD CLOTTING FACTOR 8; BLOOD CLOTTING INHIBITOR; CYCLOPHOSPHAMIDE; IMMUNOSUPPRESSIVE AGENT; PREDNISOLONE; RECOMBINANT PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; COHORT ANALYSIS; DRUG ANTAGONISM; DRUG COMBINATION; FEMALE; FOLLOW UP; HEMOPHILIA A; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BLOOD COAGULATION FACTOR INHIBITORS; COHORT STUDIES; CYCLOPHOSPHAMIDE; DRUG THERAPY, COMBINATION; FACTOR VIIA; FACTOR VIII; FEMALE; FOLLOW-UP STUDIES; HEMOPHILIA A; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ISOANTIBODIES; MALE; MIDDLE AGED; PREDNISOLONE; RECOMBINANT PROTEINS; TREATMENT OUTCOME;

EID: 34247887071     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01306.x     Document Type: Article

References (31)

1. Collins P, Macartney N, Davies R, Lees S, Giddings J, Majer R. A population based, unselected, consecutive cohort of patients with acquired haemophilia A. Br J Haematol 2004; 124: 86-90.
2. Cohen AJ, Kessler CM. Acquired inhibitors. Baillieres Clin Haematol 1996; 9: 331-54.
3. Boggio LN, Green D. Acquired hemophilia. Rev Clin Exp Hematol 2001; 5: 389-404.
4. Brackmann HH, Oldenburg J, Schwaab R. Immune tolerance for the treatment of factor VIII inhibitors- twenty years' 'bonn protocol'. Vox Sang 1996; 70 (Suppl. 1): 30-5.
5. Green D, Lechner K. A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thromb Haemost 1981; 45: 200-3.
6. Lusher JM. Perspectives on the use of factor IX complex concentrates in the treatment of bleeding in persons with acquired factor VIII inhibition. Am J Med 1991; 91: 30S-4S.
7. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. French FEIBA Study Group. Factor eight bypassing activity. Thromb Haemost 1997; 77: 1113-9.
8. Kessler CM, Ludlam CA. The treatment of acquired factor VIII inhibitors: worldwide experience with porcine factor VIII concentrate. International Acquired Hemophilia Study Group. Semin Hematol 1993; 30 (2 Suppl. 1): 22-7.
9. Hay CR, Negrier C, Ludlam CA. The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study. Thromb Haemost 1997; 78: 1463-7.
10. Spero JA, Lewis JH, Hasiba U. Corticosteroid therapy for acquired F VIII:C inhibitors. Br J Haematol 1981; 48: 635-42.
11. Green D. Immunosuppression of factor VIII inhibitors in nonhemophilic patients. Semin Hematol 1993; 30 (2 Suppl. 1): 28-31.
12. Green D, Rademaker AW, Briet E. A prospective, randomized trial of prednisone and cyclophosphamide in the treatment of patients with factor VIII autoantibodies. Thromb Haemost 1993; 70: 753-7.
13. Brox AG, Laryea H, Pelletier M. Successful treatment of acquired factor VIII inhibitors with cyclosporin. Am J Hematol 1998; 57: 87-8.
14. Stasi R, Brunetti M, Stipa E, Amadori S. Selective B-cell depletion with rituximab for the treatment of patients with acquired hemophilia. Blood 2004; 103: 4424-8.
15. Zeitler H, Ulrich-Merzenich G, Hess L et al. Treatment of acquired hemophilia by the Bonn-Malmo Protocol: documentation of an in-vivo immunomodulating concept. Blood 2005; 105: 2287-93.
16. Kessler CM. An introduction to factor VIII inhibitors: the detection and quantitation. Am J Med 1991; 91: 1S-5S.
17. Delgado J, Jimenez-Yuste V, Hernandez-Navarro F, Villar A. Acquired haemophilia: review and metaanalysis focused on therapy and prognostic factors. Br J Haematol 2003; 121: 21-35.
18. Lottenberg R, Kentro TB, Kitchens CS. Acquired hemophilia. A natural history study of 16 patients with factor VIII inhibitors receiving little or no therapy. Arch Intern Med 1987; 147: 1077-81.
19. Grunewald M, Beneke H, Guthner C, Germowitz A, Brommer A, Griesshammer M. Acquired haemophilia: experiences with a standardized approach. Haemophilia 2001; 7: 164-9.
20. Saxena R, Mishra DK, Kashyap R, Choudhry VP, Mahapatra M, Bhargava M. Acquired haemophilia - a study of ten cases. Haemophilia 2000; 6: 78-83.
21. Bayer RL, Lichtman SM, Allen SL et al. Acquired factor VIII inhibitors-successful treatment with an oral outpatient regimen. Am J Hematol 1999; 60: 70-1.
22. Shaffer LG, Phillips MD. Successful treatment of acquired hemophilia with oral immunosuppressive therapy. Ann Intern Med 1997; 127: 206-9.
23. Huang YW, Saidi P, Philipp C. Acquired factor VIII inhibitors in non-haemophilic patients: clinical experience of 15 cases. Haemophilia 2004; 10: 713-21.
24. Lian EC, Larcada AF, Chiu AY. Combination immunosuppressive therapy after factor VIII infusion for acquired factor VIII inhibitor. Ann Intern Med 1989; 110: 774-8.
25. Sohngen D, Specker C, Bach D et al. Acquired factor VIII inhibitors in nonhemophilic patients. Ann Hematol 1997; 74: 89-93.
26. Bossi P, Cabane J, Ninet J et al. Acquired hemophilia due to factor VIII inhibitors in 34 patients. Am J Med 1998; 105: 400-8.
27. Nemes L, Pitlik E. New protocol for immune tolerance induction in acquired hemophilia. Haematologica 2000; 85 (10 Suppl.): 64-8.
28. Sallah S, Singh P, Hanrahan LR. Antibodies against factor VIII in patients with solid tumors: successful treatment of cancer may suppress inhibitor formation. Haemostasis 1998; 28: 244-9.
29. Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin. Lancet 1984; 2: 765-8.
30. Schwartz RS, Gabriel DA, Aledort LM, Green D, Kessler CM. A prospective study of treatment of acquired (autoimmune) factor VIII inhibitors with high-dose intravenous gammaglobulin. Blood 1995; 86: 797-804.
31. Crenier L, Ducobu J, des Grottes JM, Cerny J, Delaunoit C, Capel P. Low response to high-dose intravenous immunoglobulin in the treatment of acquired factor VIII inhibitor. Br J Haematol 1996; 95: 750-3.